Frontiers in Genetics (Sep 2022)
Vici syndrome in Israel: Clinical and molecular insights
- Odelia Chorin,
- Odelia Chorin,
- Odelia Chorin,
- Yoel Hirsch,
- Rachel Rock,
- Rachel Rock,
- Rachel Rock,
- Liat Salzer Sheelo,
- Liat Salzer Sheelo,
- Yael Goldberg,
- Yael Goldberg,
- Hanna Mandel,
- Hanna Mandel,
- Tova Hershkovitz,
- Tova Hershkovitz,
- Nicole Fleischer,
- Lior Greenbaum,
- Lior Greenbaum,
- Lior Greenbaum,
- Uriel Katz,
- Uriel Katz,
- Ortal Barel,
- Ortal Barel,
- Nasrin Hamed,
- Nasrin Hamed,
- Bruria Ben-Zeev,
- Bruria Ben-Zeev,
- Shoshana Greenberger,
- Shoshana Greenberger,
- Shoshana Greenberger,
- Nadra Nasser Samra,
- Nadra Nasser Samra,
- Michal Stern Zimmer,
- Michal Stern Zimmer,
- Michal Stern Zimmer,
- Annick Raas-Rothschild,
- Annick Raas-Rothschild,
- Ben Pode-Shakked,
- Ben Pode-Shakked,
- Ben Pode-Shakked
Affiliations
- Odelia Chorin
- The Institute for Rare Diseases, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel
- Odelia Chorin
- The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Ramat Gan, Israel
- Odelia Chorin
- Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel
- Yoel Hirsch
- Dor Yeshorim, Committee for Prevention of Jewish Genetic Diseases, New York, NY, United States
- Rachel Rock
- The Institute for Rare Diseases, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel
- Rachel Rock
- The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Ramat Gan, Israel
- Rachel Rock
- Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel
- Liat Salzer Sheelo
- Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel
- Liat Salzer Sheelo
- Raphael Recanati Genetic Institute, Rabin Medical Center—Beilinson Hospital, Petah Tikva, Israel
- Yael Goldberg
- Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel
- Yael Goldberg
- Raphael Recanati Genetic Institute, Rabin Medical Center—Beilinson Hospital, Petah Tikva, Israel
- Hanna Mandel
- Unit of Inherited Metabolic Disorders, Ziv Medical Center, Safed, Israel
- Hanna Mandel
- Institute of Human Genetics, Ziv Medical Center, Safed, Israel
- Tova Hershkovitz
- The Genetics Institute, Rambam Health Care Campus, Haifa, Israel
- Tova Hershkovitz
- Ruth and Bruce Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel
- Nicole Fleischer
- 0FDNA Inc, Boston, MA, United States
- Lior Greenbaum
- The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Ramat Gan, Israel
- Lior Greenbaum
- Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel
- Lior Greenbaum
- 1The Joseph Sagol Neusroscience Center, Sheba Medical Center, Ramat Gan, Israel
- Uriel Katz
- Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel
- Uriel Katz
- 2Pediatric Heart Institute, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel
- Ortal Barel
- 3The Genomic Unit, Sheba Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel
- Ortal Barel
- 4The Wohl Institute for Translational Medicine and Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel
- Nasrin Hamed
- Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel
- Nasrin Hamed
- 5Pediatric Neurology Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel
- Bruria Ben-Zeev
- Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel
- Bruria Ben-Zeev
- 5Pediatric Neurology Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel
- Shoshana Greenberger
- Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel
- Shoshana Greenberger
- 6The Talpiot Medical Leadership Program, Sheba Medical Center, Ramat Gan, Israel
- Shoshana Greenberger
- 7Department of Dermatology, Sheba Medical Center, Ramat Gan, Israel
- Nadra Nasser Samra
- Institute of Human Genetics, Ziv Medical Center, Safed, Israel
- Nadra Nasser Samra
- 8Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
- Michal Stern Zimmer
- Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel
- Michal Stern Zimmer
- 5Pediatric Neurology Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel
- Michal Stern Zimmer
- 9Pediatric Department B, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel
- Annick Raas-Rothschild
- The Institute for Rare Diseases, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel
- Annick Raas-Rothschild
- Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel
- Ben Pode-Shakked
- The Institute for Rare Diseases, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel
- Ben Pode-Shakked
- Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel
- Ben Pode-Shakked
- 6The Talpiot Medical Leadership Program, Sheba Medical Center, Ramat Gan, Israel
- DOI
- https://doi.org/10.3389/fgene.2022.991721
- Journal volume & issue
-
Vol. 13
Abstract
Introduction: Vici Syndrome is a rare, severe, neurodevelopmental/neurodegenerative disorder with multi-systemic manifestations presenting in infancy. It is mainly characterized by global developmental delay, seizures, agenesis of the corpus callosum, hair and skin hypopigmentation, bilateral cataract, and varying degrees of immunodeficiency, among other features. Vici Syndrome is caused by biallelic pathogenic variants in EPG5, resulting in impaired autophagy. Thus far, the condition has been reported in less than a hundred individuals.Objective and Methods: We aimed to characterize the clinical and molecular findings in individuals harboring biallelic EPG5 variants, recruited from four medical centers in Israel. Furthermore, we aimed to utilize a machine learning-based tool to assess facial features of Vici syndrome.Results: Eleven cases of Vici Syndrome from five unrelated families, one of which was diagnosed prenatally with subsequent termination of pregnancy, were recruited. A total of five disease causing variants were detected in EPG5: two novel: c.2554-5A>G and c.1461delC; and 3 previously reported: c.3447G>A, c.5993C>G, and c.1007A>G, the latter previously identified in several patients of Ashkenazi-Jewish (AJ) descent. Amongst 140,491 individuals screened by the Dor Yeshorim Program, we show that the c.1007A>G variant has an overall carrier frequency of 0.45% (1 in 224) among AJ individuals. Finally, based on two-dimensional facial photographs of individuals with Vici syndrome (n = 19), a composite facial mask was created using the DeepGestalt algorithm, illustrating facial features typical of this disorder.Conclusion: We report on ten children and one fetus from five unrelated families, affected with Vici syndrome, and describe prenatal and postnatal characteristics. Our findings contribute to the current knowledge regarding the molecular basis and phenotypic features of this rare syndrome. Additionally, the deep learning-based facial gestalt adds to the clinician’s diagnostic toolbox and may aid in facilitating identification of affected individuals.
Keywords
- EPG5
- Vici syndrome
- congenital cataract
- agenesis of corpus callosum
- global developmental delay
- cardiomyopathy